ARTOFA 5 TABLET

Product Description

ARTOFA 5 TABLET
Targeted Therapy for Autoimmune Conditions Tofacitinib 5mg Tablet

Product Description:
ARTOFA 5 TABLET contains Tofacitinib 5mg, a powerful Janus Kinase (JAK) inhibitor indicated for the treatment of autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It offers targeted immunomodulation by blocking specific pathways responsible for inflammation and joint damage.

Manufactured by Agrosaf Pharmaceuticals Pvt. Ltd., ARTOFA 5 ensures international-grade quality, reliable efficacy, and is suitable for both retail and institutional distribution in chronic care segments.

Key Benefits:

• Relieves joint pain, stiffness, and swelling in inflammatory arthritis

• Convenient oral tablet for long-term management

• Improves mobility and quality of life in chronic autoimmune conditions

• Acts on intracellular signaling to reduce inflammatory response

• Well-tolerated and supported by global treatment guidelines

Therapeutic Indications:

• Rheumatoid Arthritis (moderate to severe)

• Psoriatic Arthritis

• Ulcerative Colitis (when conventional therapies are inadequate)

Target Buyers:
Ideal for rheumatology distributors, chronic care product wholesalers, hospital pharmacies, government tenders, and bulk medicine buyers focused on immunology and autoimmune disease management.

Packaging:

Secure blister packs for ease of dispensing, with bulk packaging available for hospitals and large-scale buyers.

ARTOFA 5 TABLET Targeted autoimmune relief, trusted by healthcare professionals. Quality by Agrosaf Pharmaceuticals.